{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:20:53Z","timestamp":1788380453980,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Herbal Medicines"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.chmed.2025.11.001","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:51:51Z","timestamp":1762307511000},"page":"643-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Puerarin as a multifaceted anticancer agent: Mechanisms, targets, and therapeutic potential across multiple cancers"],"prefix":"10.1016","volume":"18","author":[{"given":"Aida","family":"Alizamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Khanaghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Mirzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Nokhodchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laleh","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-1446","authenticated-orcid":false,"given":"Bita","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chmed.2025.11.001_b0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/CMAR.S233567","article-title":"Molecular mechanisms of anticancer activities of puerarin","volume":"12","author":"Ahmad","year":"2020","journal-title":"Cancer Management and Research"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40360-018-0216-3","article-title":"Absolute oral bioavailability and disposition kinetics of puerarin in female rats","volume":"19","author":"Anukunwithaya","year":"2018","journal-title":"BMC Pharmacology & Toxicology"},{"issue":"8","key":"10.1016\/j.chmed.2025.11.001_b0015","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/jf021114s","article-title":"Evaluation of the estrogenic effects of legume extracts containing phytoestrogens","volume":"51","author":"Boue","year":"2003","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"3","key":"10.1016\/j.chmed.2025.11.001_b0020","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10.1016\/j.chmed.2025.11.001_b0025","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1080\/01635581.2023.2168023","article-title":"Puerarin suppresses glycolysis and increases cisplatin chemosensitivity in oral squamous cell carcinoma via FBXW7\/mTOR signaling","volume":"75","author":"Cai","year":"2023","journal-title":"Nutrition and Cancer"},{"key":"10.1016\/j.chmed.2025.11.001_b0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fitote.2013.03.004","article-title":"Pharmacokinetics of puerarin in pregnant rats at different stages of gestation after oral administration","volume":"86","author":"Cao","year":"2013","journal-title":"Fitoterapia"},{"issue":"9","key":"10.1016\/j.chmed.2025.11.001_b0035","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3109\/13880209.2015.1127980","article-title":"In vitro and in vivo antitumour activities of puerarin 6''-O-xyloside on human lung carcinoma A549 cell line via the induction of the mitochondria-mediated apoptosis pathway","volume":"54","author":"Chen","year":"2016","journal-title":"Pharmaceutical Biology"},{"key":"10.1016\/j.chmed.2025.11.001_b0040","article-title":"Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII","volume":"13","author":"Chen","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"15","key":"10.1016\/j.chmed.2025.11.001_b0045","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1158\/1078-0432.CCR-09-0640","article-title":"Interleukin-6 regulates androgen synthesis in prostate cancer cells","volume":"15","author":"Chun","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"39","key":"10.1016\/j.chmed.2025.11.001_b0050","first-page":"8203","article-title":"The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis - current status","volume":"28","author":"Dallavalasa","year":"2021","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.chmed.2025.11.001_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118644","article-title":"Colon-specific microspheres loaded with puerarin reduce tumorigenesis and metastasis in colitis-associated colorectal cancer","volume":"570","author":"Deng","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"issue":"12","key":"10.1016\/j.chmed.2025.11.001_b0060","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/2767-9764.CRC-22-0262","article-title":"IL-1\u03b2 expression driven by androgen receptor absence or inactivation promotes prostate cancer bone metastasis","volume":"2","author":"DiNatale","year":"2022","journal-title":"Cancer Research Communications"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/cbr.2019.3382","article-title":"Puerarin inhibits the progression of bladder cancer by regulating circ_0020394\/miR-328-3p\/NRBP1 axis","volume":"37","author":"Du","year":"2022","journal-title":"Cancer Biotherapy & Radiopharmaceuticals"},{"issue":"9","key":"10.1016\/j.chmed.2025.11.001_b0070","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211040762","article-title":"Puerarin induces platinum-resistant epithelial ovarian cancer cell apoptosis by targeting SIRT1","volume":"49","author":"Duan","year":"2021","journal-title":"The Journal of International Medical Research"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12013-014-0207-y","article-title":"Puerarin induced in mantle cell lymphoma apoptosis and its possible mechanisms involving multi-signaling pathway","volume":"71","author":"Gan","year":"2015","journal-title":"Cell Biochemistry and Biophysics"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0080","first-page":"1554","article-title":"Puerarin leads to K562 cell apoptosis of chronic myelogenous leukemia via induction of autophagy","volume":"22","author":"Gao","year":"2017","journal-title":"Journal of B.U.ON."},{"key":"10.1016\/j.chmed.2025.11.001_b0085","doi-asserted-by":"crossref","unstructured":"Gao, J. M., Wang, Z. P., Meng, X. P., Chen, T. S., & Wang, Y. F. (2018). Anti-hepatocarcinoma effects of puerarin-nanoethosomes against human HepG2 cells. Nanophotonics and Micro\/Nano Optics IV. October 11-13, 2018. Beijing, China. SPIE, 41.","DOI":"10.1117\/12.2500149"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0090","first-page":"5267","article-title":"miR-125b expression in ovarian cancer cell lines","volume":"9","author":"Guo","year":"2016","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"4","key":"10.1016\/j.chmed.2025.11.001_b0095","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.3892\/mmr.2014.3016","article-title":"Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma","volume":"11","author":"Guo","year":"2015","journal-title":"Molecular Medicine Reports"},{"issue":"7","key":"10.1016\/j.chmed.2025.11.001_b0100","first-page":"632","article-title":"Inhibitory effects of puerarin on invasion and metastasis of oophoroma cells HO-8910","volume":"29","author":"Han","year":"2009","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0105","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/jf062796c","article-title":"Puerarin and conjugate bases as radical scavengers and antioxidants: Molecular mechanism and synergism with beta-carotene","volume":"55","author":"Han","year":"2007","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"12","key":"10.1016\/j.chmed.2025.11.001_b0110","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1158\/1541-7786.MCR-19-0540","article-title":"Prostate tumor cell-derived IL-1\u03b2 induces an inflammatory phenotype in bone marrow adipocytes and reduces sensitivity to docetaxel via lipolysis-dependent mechanisms","volume":"17","author":"Herroon","year":"2019","journal-title":"Molecular Cancer Research"},{"issue":"7","key":"10.1016\/j.chmed.2025.11.001_b0115","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/mnfr.200900146","article-title":"Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-\u03baB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7\/adr cells","volume":"54","author":"Hien","year":"2010","journal-title":"Molecular Nutrition & Food Research"},{"issue":"4","key":"10.1016\/j.chmed.2025.11.001_b0120","first-page":"1731","article-title":"Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis","volume":"39","author":"Hu","year":"2018","journal-title":"Oncology Reports"},{"key":"10.1016\/j.chmed.2025.11.001_b0125","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.2147\/CMAR.S253327","article-title":"Puerarin enhances the anti-tumor effect of cisplatin on drug-resistant A549 cancer in vivo and in vitro through activation of the Wnt signaling pathway","volume":"12","author":"Huang","year":"2020","journal-title":"Cancer Management and Research"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0130","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4149\/neo_2020_191107N1145","article-title":"Puerarin alleviates the progression of non-small cell lung cancer by regulating the miR-342\/CCND1 axis","volume":"67","author":"Huang","year":"2020","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0135","first-page":"543","article-title":"Puerarin suppresses cell growth and migration in HPV-positive cervical cancer cells by inhibiting the PI3K\/mTOR signaling pathway","volume":"18","author":"Jia","year":"2019","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0140","first-page":"167","article-title":"Puerarin inhibits bladder cancer cell proliferation through the mTOR\/p70S6K signaling pathway","volume":"15","author":"Jiang","year":"2018","journal-title":"Oncology Letters"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0145","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: The framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.chmed.2025.11.001_b0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-023-05724-0","article-title":"FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2","volume":"14","author":"Jim\u00e9nez-Izquierdo","year":"2023","journal-title":"Cell Death & Disease"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0155","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3892\/ijo.2017.3841","article-title":"Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK\/ERK 1\/2 pathway","volume":"50","author":"Kang","year":"2017","journal-title":"International Journal of Oncology"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/molecules22060939","article-title":"Pharmacokinetics and tissue distribution kinetics of puerarin in rats using indirect competitive ELISA","volume":"22","author":"Kong","year":"2017","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.chmed.2025.11.001_b0165","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","author":"Kopecka","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.chmed.2025.11.001_b0170","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.52586\/5058","article-title":"Puerarin-an isoflavone with beneficial effects on bone health","volume":"26","author":"Kulczy\u0144ski","year":"2021","journal-title":"Frontiers in Bioscience"},{"issue":"11","key":"10.1016\/j.chmed.2025.11.001_b0175","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.21037\/tcr-22-2246","article-title":"Inhibitory role of puerarin on the A549 lung cancer cell line","volume":"11","author":"Lang","year":"2022","journal-title":"Translational Cancer Research"},{"issue":"3","key":"10.1016\/j.chmed.2025.11.001_b0180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.explore.2022.04.001","article-title":"A potential treatment option for advanced non-small cell lung cancer: Three cases","volume":"19","author":"Lee","year":"2023","journal-title":"Explore"},{"issue":"1\u20132","key":"10.1016\/j.chmed.2025.11.001_b0185","first-page":"133","article-title":"Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats","volume":"466","author":"Li","year":"2014","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.chmed.2025.11.001_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172483","article-title":"Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks","volume":"858","author":"Li","year":"2019","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0195","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/21655979.2020.1868733","article-title":"Puerarin induces apoptosis in prostate cancer cells via inactivation of the Keap1\/Nrf2\/ARE signaling pathway","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0200","first-page":"205","article-title":"Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer","volume":"19","author":"Li","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"7","key":"10.1016\/j.chmed.2025.11.001_b0205","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/01635581.2023.2216922","article-title":"Puerarin induces ferroptosis in colorectal cancer cells via triggering NCOA4 upregulation","volume":"75","author":"Lian","year":"2023","journal-title":"Nutrition and Cancer"},{"issue":"3","key":"10.1016\/j.chmed.2025.11.001_b0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jep.2012.10.011","article-title":"Transport properties of puerarin and effect of Radix Angelicae Dahuricae extract on the transport of puerarin in Caco-2 cell model","volume":"144","author":"Liang","year":"2012","journal-title":"Journal of Ethnopharmacology"},{"issue":"10","key":"10.1016\/j.chmed.2025.11.001_b0215","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.3390\/ijms25105222","article-title":"Puerarin\u2014a promising flavonoid: Biosynthesis, extraction methods, analytical techniques, and biological effects","volume":"25","author":"Liga","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/j.chmed.2025.11.001_b0220","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1007\/s00210-024-03158-9","article-title":"Mechanistic analyses reveal that Pueraria montana var. Lobata (Willd.) is effective in inhibiting ovarian cancer progression","volume":"397","author":"Lin","year":"2024","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"4","key":"10.1016\/j.chmed.2025.11.001_b0225","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbrc.2008.10.178","article-title":"Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells","volume":"378","author":"Lin","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.chmed.2019.04.004","article-title":"Applications of Pueraria lobata in treating diabetics and reducing alcohol drinking","volume":"11","author":"Liu","year":"2019","journal-title":"Chinese Herbal Medicines"},{"key":"10.1016\/j.chmed.2025.11.001_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175695","article-title":"Therapeutic potential of puerarin against cerebral diseases: From bench to bedside","volume":"953","author":"Liu","year":"2023","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.chmed.2025.11.001_b0240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.biopha.2017.05.102","article-title":"Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-\u03baB and Erk pathway","volume":"92","author":"Liu","year":"2017","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.chmed.2025.11.001_b0245","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3727\/096504018X15178736525106","article-title":"Puerarin inhibits proliferation and induces apoptosis by upregulation of miR-16 in bladder cancer cell line T24","volume":"26","author":"Liu","year":"2018","journal-title":"Oncology Research"},{"issue":"22","key":"10.1016\/j.chmed.2025.11.001_b0250","first-page":"3391","article-title":"Stability of PEGylated puerarin under different storage conditions","volume":"37","author":"Liu","year":"2012","journal-title":"China Journal of Chinese Materia Medica"},{"issue":"25","key":"10.1016\/j.chmed.2025.11.001_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202307521","article-title":"An injectable puerarin depot can potentiate chimeric antigen receptor natural killer cell immunotherapy against targeted solid tumors by reversing tumor immunosuppression","volume":"20","author":"Liu","year":"2024","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0260","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4110\/in.2016.16.2.85","article-title":"Regulatory roles of MAPK phosphatases in cancer","volume":"16","author":"Low","year":"2016","journal-title":"Immune Network"},{"key":"10.1016\/j.chmed.2025.11.001_b0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4028\/www.scientific.net\/AMR.1083.27","article-title":"In vitro antitumor efficacy of puerarin nanosuspension against Human HepG2 Cells","volume":"1083","author":"Lu","year":"2015","journal-title":"Advanced Materials Research"},{"issue":"3\u20134","key":"10.1016\/j.chmed.2025.11.001_b0270","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jchromb.2009.12.002","article-title":"Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: Similar metabolic profiles in liver and intestine of rats","volume":"878","author":"Luo","year":"2010","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/j.chmed.2025.11.001_b0275","first-page":"585","article-title":"Effect of puerarin on proliferation and apoptosis of human gastric cancer MGC-803 and AGS cells","volume":"6","author":"Ma","year":"2013","journal-title":"Cancer Research and Clinic"},{"issue":"4","key":"10.1016\/j.chmed.2025.11.001_b0280","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1574892819666230908110107","article-title":"Comprehensive genomic analysis of puerarin in inhibiting bladder urothelial carcinoma cell proliferation and migration","volume":"19","author":"Ma","year":"2024","journal-title":"Recent Patents on Anti-Cancer Drug Discovery"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0285","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.fitote.2010.01.019","article-title":"Puerarin exhibits weak estrogenic activity in female rats","volume":"81","author":"Malaivijitnond","year":"2010","journal-title":"Fitoterapia"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0290","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/1871520620666200227091811","article-title":"A critical review on anticancer mechanisms of natural flavonoid puerarin","volume":"20","author":"Murahari","year":"2020","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/a-1271-7092","article-title":"Comparative pharmacokinetics of puerarin alone and in Pueraria mirifica extract in female Cynomolgus monkeys","volume":"87","author":"Namken","year":"2021","journal-title":"Planta Medica"},{"issue":"3","key":"10.1016\/j.chmed.2025.11.001_b0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.chmed.2025.11.001_b0305","series-title":"Quantitative analysis of isoflavonoids and estrogenic activity on human breast cancer cells (MCF-7) of cultivated white Kwao Krua Pueraria mirifica","first-page":"38","author":"Nimpao","year":"2006"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0310","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/07391102.2020.1819425","article-title":"Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation","volume":"40","author":"Ojo","year":"2022","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"issue":"3","key":"10.1016\/j.chmed.2025.11.001_b0315","doi-asserted-by":"crossref","first-page":"407","DOI":"10.38001\/ijlsb.1089164","article-title":"Antitumor activity of etoposide, puerarin, galangin and their combinations in neuroblastoma cells","volume":"5","author":"Oltulu","year":"2022","journal-title":"International Journal of Life Sciences and Biotechnology"},{"issue":"7","key":"10.1016\/j.chmed.2025.11.001_b0320","first-page":"680","article-title":"Effects of puerarin on proliferation, apoptosis, migration and invasion of hormone-independent prostate cancer cells","volume":"38","author":"Pan","year":"2018","journal-title":"Tumor"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/acm.2006.12.543","article-title":"Pharmacokinetic profile of the isoflavone puerarin after acute and repeated administration of a novel kudzu extract to human volunteers","volume":"12","author":"Penetar","year":"2006","journal-title":"Journal of Alternative and Complementary Medicine"},{"key":"10.1016\/j.chmed.2025.11.001_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118491","article-title":"A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by traditional chinese medicine","volume":"334","author":"Peng","year":"2024","journal-title":"Journal of Ethnopharmacology"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phymed.2008.09.004","article-title":"Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography\u2013tandem mass spectrometry","volume":"16","author":"Prasain","year":"2009","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0340","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chmed.2021.12.003","article-title":"Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go","volume":"14","author":"Qin","year":"2022","journal-title":"Chinese Herbal Medicines"},{"issue":"32","key":"10.1016\/j.chmed.2025.11.001_b0345","doi-asserted-by":"crossref","first-page":"28003","DOI":"10.1021\/acsomega.2c01921","article-title":"Integrating UPLC-HR-MS\/MS, network pharmacology, and experimental validation to uncover the mechanisms of jin\u2019gan capsules against breast cancer","volume":"7","author":"Qiu","year":"2022","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0350","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1248\/cpb.55.800","article-title":"Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin","volume":"55","author":"Quan","year":"2007","journal-title":"Chemical & Pharmaceutical Bulletin"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0355","first-page":"296","article-title":"Inhibitory effect of flavonoids of puerarin on proliferation of different human acute myeloid leukemia cell lines in vitro","volume":"18","author":"Shao","year":"2010","journal-title":"Journal of Experimental Hematology"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/pcan.2011.6","article-title":"IL-10 polymorphisms and prostate cancer risk: A meta-analysis","volume":"14","author":"Shao","year":"2011","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"10.1016\/j.chmed.2025.11.001_b0365","article-title":"FBXW7 and the hallmarks of cancer: Underlying mechanisms and prospective strategies","volume":"12","author":"Shen","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s10020-021-00295-2","article-title":"The role of the microbiome in ovarian cancer: Mechanistic insights into oncobiosis and to bacterial metabolite signaling","volume":"27","author":"Sipos","year":"2021","journal-title":"Molecular Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1359-6101(00)00021-6","article-title":"Interleukin-6 and prostate cancer progression","volume":"12","author":"Smith","year":"2001","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"11","key":"10.1016\/j.chmed.2025.11.001_b0380","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ardp.201500183","article-title":"Targeting human poly (ADP-ribose) polymerase-1 with natural medicines and its potential applications in ovarian cancer therapeutics","volume":"348","author":"Song","year":"2015","journal-title":"Archiv der Pharmazie"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12906-024-04569-0","article-title":"Effects and mechanisms of puerarin against neuroblastoma: Insights from bioinformatics and in vitro experiments","volume":"24","author":"Sui","year":"2024","journal-title":"BMC Complementary Medicine and Therapies"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0390","first-page":"326","article-title":"Apoptosis of NB4 cells induced by flavonoids of puerarin in vitro","volume":"18","author":"Tang","year":"2010","journal-title":"Journal of Experimental Hematology"},{"issue":"7","key":"10.1016\/j.chmed.2025.11.001_b0395","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/1440-1681.13294","article-title":"Puerarin 6\u2033-O-xyloside suppresses growth, self-renewal and invasion of lung cancer stem-like cells derived from A549 cells via regulating Akt\/c-Myc signalling","volume":"47","author":"Tao","year":"2020","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2013.10.001","article-title":"Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat","volume":"458","author":"Tu","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0405","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3892\/mmr.2014.2539","article-title":"Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer","volume":"10","author":"Wang","year":"2014","journal-title":"Molecular Medicine Reports"},{"issue":"18","key":"10.1016\/j.chmed.2025.11.001_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004721","article-title":"A novel stimuli-responsive injectable antibacterial hydrogel to achieve synergetic photothermal\/gene-targeted therapy towards uveal melanoma","volume":"8","author":"Wang","year":"2021","journal-title":"Advanced Science"},{"issue":"1\u20132","key":"10.1016\/j.chmed.2025.11.001_b0415","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijpharm.2012.10.021","article-title":"In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity","volume":"441","author":"Wang","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"issue":"23","key":"10.1016\/j.chmed.2025.11.001_b0420","first-page":"2834","article-title":"Metabolic kinetic of puerarin in beagle liver microsomal by HPLC-ESI-MS","volume":"33","author":"Wen","year":"2008","journal-title":"China Journal of Chinese Materia Medica"},{"issue":"9","key":"10.1016\/j.chmed.2025.11.001_b0425","doi-asserted-by":"crossref","first-page":"52","DOI":"10.53388\/TMR20240209001","article-title":"Puerarin modulation of CENPA affects downstream PLK1 and CCNB1 expression to inhibit bladder cancer cell proliferation","volume":"9","author":"Xu","year":"2024","journal-title":"Traditional Medicine Research"},{"key":"10.1016\/j.chmed.2025.11.001_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119769","article-title":"Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model","volume":"235","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.chmed.2025.11.001_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116675","article-title":"Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate\/HIF-1\u03b1\/IL-1\u03b2 axis","volume":"317","author":"Xu","year":"2023","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.chmed.2025.11.001_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2021.101377","article-title":"Interleukin-10 (IL-10) gene polymorphisms and prostate cancer susceptibility: Evidence from a meta-analysis","volume":"25","author":"Yadav","year":"2021","journal-title":"Gene Reports"},{"key":"10.1016\/j.chmed.2025.11.001_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119128","article-title":"Serum metabolomics and 16S rRNA amplicon sequencing reveal the role of puerarin in alleviating bone loss aggravated by antidiabetic agent pioglitazone in type 2 diabetic mice","volume":"340","author":"Yang","year":"2025","journal-title":"Journal of Ethnopharmacology"},{"issue":"14","key":"10.1016\/j.chmed.2025.11.001_b0450","first-page":"4701","article-title":"Research progress on application and mechanisms of Puerariae Lobatae Radix in treatment of physical disease comorbid with depression","volume":"54","author":"Yang","year":"2023","journal-title":"Chinese Traditional and Herbal Drugs"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0455","first-page":"195","article-title":"Puerarin in inducing apoptosis of bladder cancer cells through inhibiting SIRT1\/p53 pathway","volume":"17","author":"Ye","year":"2019","journal-title":"Oncology Letters"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0460","article-title":"Anticancer effect of puerarin on ovarian cancer progression contributes to the tumor suppressor gene expression and gut microbiota modulation","volume":"2022","author":"Ye","year":"2022","journal-title":"Journal of Immunology Research"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0465","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1039\/C9BM00111E","article-title":"Synthesis, characterization, and formulation of poly-puerarin as a biodegradable and biosafe drug delivery platform for anti-cancer therapy","volume":"7","author":"Yi","year":"2019","journal-title":"Biomaterials Science"},{"issue":"4","key":"10.1016\/j.chmed.2025.11.001_b0470","first-page":"627","article-title":"Mechanism of puerarin targeting the mitochondria to inhibit proliferation and invasion of breast cancer cells","volume":"59","author":"Yu","year":"2024","journal-title":"Acta Universitatis Medicinalis Anhui"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2005.06.022","article-title":"Induction of apoptosis by puerarin in colon cancer HT-29 cells","volume":"238","author":"Yu","year":"2006","journal-title":"Cancer Letters"},{"issue":"6","key":"10.1016\/j.chmed.2025.11.001_b0480","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3892\/ol.2014.2534","article-title":"Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma","volume":"8","author":"Zeng","year":"2014","journal-title":"Oncology Letters"},{"issue":"2","key":"10.1016\/j.chmed.2025.11.001_b0485","doi-asserted-by":"crossref","first-page":"714","DOI":"10.21037\/tcr.2019.03.25","article-title":"Retraction: Cyclooxygenase-2 mediates puerarin to inhibit the invasion and metastasis of lung cancer A549 cells","volume":"8","author":"Zeng","year":"2019","journal-title":"Translational Cancer Research"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0490","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/10717544.2019.1660732","article-title":"Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional chinese medicine","volume":"26","author":"Zhang","year":"2019","journal-title":"Drug Delivery"},{"issue":"19","key":"10.1016\/j.chmed.2025.11.001_b0495","first-page":"2000","article-title":"Puerarin inhibits the proliferation and apoptosis of MCF-7 breast cancer cells by down-regulating the expression of matrix metalloproteinase-16","volume":"38","author":"Zhang","year":"2018","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"10.1016\/j.chmed.2025.11.001_b0500","article-title":"Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K\/Akt\/Nrf2 signaling pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0505","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3892\/mmr.2014.2512","article-title":"Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells","volume":"10","author":"Zhang","year":"2014","journal-title":"Molecular Medicine Reports"},{"issue":"8","key":"10.1016\/j.chmed.2025.11.001_b0510","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.21873\/anticanres.12744","article-title":"Puerarin induces hepatocellular carcinoma cell apoptosis modulated by MAPK signaling pathways in a dose-dependent manner","volume":"37","author":"Zhang","year":"2017","journal-title":"Anticancer Research"},{"issue":"5","key":"10.1016\/j.chmed.2025.11.001_b0515","first-page":"5557","article-title":"Puerarin 6\u2033-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncology Letters"},{"key":"10.1016\/j.chmed.2025.11.001_b0525","first-page":"117","article-title":"Role of microRNA-125b in human ovarian cancer cell SKOV3 induced apoptosis by puerarin. Journal of Modern","volume":"32(5), 13\u201315","author":"Zhang","year":"2017","journal-title":"Laboratory Medicine"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0520","first-page":"91","article-title":"Puerarin inhibits the proliferation, invasion, and migration of non-small cell lung cancer cells through regulating miR-490\/denticleless E3 ubiquitin protein ligase","volume":"44","author":"Zhang","year":"2022","journal-title":"Acta Academiae Medicinae Sinicae"},{"issue":"8","key":"10.1016\/j.chmed.2025.11.001_b0530","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jcph.96","article-title":"Radix puerariae: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"53","author":"Zhang","year":"2013","journal-title":"The Journal of Clinical Pharmacology"},{"key":"10.1016\/j.chmed.2025.11.001_b0535","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: From molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.chmed.2025.11.001_b0540","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/10717544.2021.1934187","article-title":"Engineering of hybrid anticancer drug-loaded polymeric nanoparticles delivery system for the treatment and care of lung cancer therapy","volume":"28","author":"Zhao","year":"2021","journal-title":"Drug Delivery"},{"key":"10.1016\/j.chmed.2025.11.001_b0545","article-title":"Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation","volume":"13","author":"Zhou","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"17","key":"10.1016\/j.chmed.2025.11.001_b0550","first-page":"4089","article-title":"Molecular mechanism of Puerariae Lobatae Radix in treatment of hepatocellular carcinoma based on network pharmacology","volume":"45","author":"Zhou","year":"2020","journal-title":"China Journal of Chinese Materia Medica"},{"issue":"4","key":"10.1016\/j.chmed.2025.11.001_b0560","doi-asserted-by":"crossref","first-page":"e8882","DOI":"10.1590\/1414-431x20198882","article-title":"Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN\/AKT signaling to suppress the epithelial-mesenchymal transition","volume":"53","author":"Zhou","year":"2020","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.chmed.2025.11.001_b0555","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.771793","article-title":"Effects of puerarin on the prevention and treatment of cardiovascular diseases","volume":"12","author":"Zhou","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"23","key":"10.1016\/j.chmed.2025.11.001_b0565","doi-asserted-by":"crossref","first-page":"25089","DOI":"10.18632\/aging.203725","article-title":"The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism","volume":"13","author":"Zhu","year":"2021","journal-title":"Aging"}],"container-title":["Chinese Herbal Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1674638425001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1674638425001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:54:33Z","timestamp":1788378873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1674638425001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1674638425001212"],"URL":"https:\/\/doi.org\/10.1016\/j.chmed.2025.11.001","relation":{},"ISSN":["1674-6384"],"issn-type":[{"value":"1674-6384","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Puerarin as a multifaceted anticancer agent: Mechanisms, targets, and therapeutic potential across multiple cancers","name":"articletitle","label":"Article Title"},{"value":"Chinese Herbal Medicines","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chmed.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V.","name":"copyright","label":"Copyright"}]}}